Foods high in refined carbohydrates or added sugars that quickly increase blood sugar and then cause it to drop, contributing to nausea or other GI effects
doi: 10.1016/j.tcm.2021.12.008
Medicaid spending on GLP-1s for all conditions increased from $597.3 million for about 755,000 prescriptions in 2019, to $3.9 billion for 3.8 million prescriptions in 2023, according to KFF
Resveratrol supports and alpha-naphthoflavone disrupts growth of human ovarian follicles in an in vitro tissue culture model
PMC11612315 Gong N, Xiao Q, Zhu B, et al
Beyond the improved glycaemia control, essential for the short term treatment of diabetes (188), different GLP-1RAs are powerful clinical tools for the management of diabetic kidney disease (DKD) (189) non-alcoholic steatohepatitis (NASH) (190), neuroinflammation (191), obesity and cardiovascular disease (192195)